protocol of a systematic review and thematic synthesis of qualitative research by Silvério Rodrigues, David et al.
1Silvério Rodrigues D, et al. BMJ Open 2019;9:e023832. doi:10.1136/bmjopen-2018-023832
Open access 
Primary care physicians’ decision-
making processes in the context of 
multimorbidity: protocol of a systematic 
review and thematic synthesis of 
qualitative research
David Silvério Rodrigues,  1 Paulo Faria Sousa,1 Nuno Basílio,1 Ana Antunes,  2 
Maria da Luz Antunes,3 Maria Isabel Santos,1 Bruno Heleno1
To cite: Silvério Rodrigues D, 
Sousa PF, Basílio N, et al.  
Primary care physicians’ 
decision-making processes in 
the context of multimorbidity: 
protocol of a systematic review 
and thematic synthesis of 
qualitative research. BMJ Open 
2019;9:e023832. doi:10.1136/
bmjopen-2018-023832
 ► Prepublication history and 
additional material for this paper 
are available online. To view 
please visit the journal (http:// 
dx. doi. org/ 10. 1136/ bmjopen- 
2018- 023832).
Received 25 April 2018
Revised 16 October 2018
Accepted 5 February 2019
1Family Medicine Unit, Nova 
Medical School, Nova University 
of Lisbon, Lisboa, Portugal
2Nova Medical School, Nova 
University of Lisbon, Chronic 
Diseases Research Center 
(CEDOC), Lisboa, Portugal
3Instituto Politecnico de Lisboa, 
Escola Superior de Tecnologia 
da Saude de Lisboa, Lisboa, 
Portugal
Correspondence to
Dr David Silvério Rodrigues;  
 david. rodrigues@ nms. unl. pt
Protocol
© Author(s) (or their 
employer(s)) 2019. Re-use 
permitted under CC BY-NC. No 
commercial re-use. See rights 
and permissions. Published by 
BMJ.
AbstrACt
Introduction Good patient outcomes correlate with 
the physicians’ capacity for good clinical judgement. 
Multimorbidity is common and it increases uncertainty and 
complexity in the clinical encounter. However, healthcare 
systems and medical education are centred on individual 
diseases. In consequence, recognition of the patient as 
the centre of the decision-making process becomes 
even more difficult. Research in clinical reasoning and 
medical decision in a real-world context is needed. The 
aim of the present review is to identify and synthesise 
available qualitative evidence on primary care physicians’ 
perspectives, views or experiences on decision-making 
with patients with multimorbidity.
Methods and analysis This will be a systematic 
review of qualitative research where PubMed, CINAHL, 
PsycINFO, Embase and Web of Science will be searched, 
supplemented with manual searches of reference 
lists of included studies. Qualitative studies published 
in Portuguese, Spanish and English language will be 
included, with no date limit. Studies will be eligible when 
they evaluate family physicians’ perspectives, opinions 
or perceptions on decision-making for patients with 
multimorbidity in primary care. The methodological quality 
of studies selected for retrieval will be assessed by two 
independent reviewers before inclusion in the review 
using the Critical Appraisal Skills Programme (CASP) tool. 
Thematic synthesis will be used to identify key categories 
and themes from the qualitative data. The Confidence 
in the Evidence from Reviews of Qualitative research 
approach will be used to assess how much confidence to 
place in findings from the qualitative evidence synthesis.
Ethics and dissemination This review will use published 
data. No ethical issues are foreseen. The findings will 
be disseminated to the medical community via journal 
publication and conference presentation(s).
PrOsPErO registration number ID 91978.
IntrOduCtIOn 
rationale
Research reveals that the quality of medical 
decision-making is highly related to patient 
safety and reports state that bad clinical deci-
sions lead to considerable morbidity and 
mortality.1 Medical decisions are at the core 
of the clinical encounter and good patient 
outcomes correlate with a physician’s capacity 
for good clinical judgement.2 
The paradoxical reality of primary care
In primary care, patients with multiple 
chronic disease are the rule and not the 
exception.3–5 Despite the actual predom-
inance of multiple chronic conditions, 
medical care remains centred on the diag-
nosis and treatment of single diseases.6 Medi-
cine moved into an era of accountability, 
scrutiny, measurement, pay for performance 
and market-based principles.7 While these 
developments aimed to increase quality, they 
reinforced fragmentation and disease-cen-
tred healthcare and make the holistic, inte-
grated and person-centred decision-making a 
difficult goal to accomplish.8
Patients with multimorbidity have complex 
needs that challenge evidence-based medical 
strengths and limitations of this study
 ► Systematic review of physicians’ perceptions on 
forces that play a role on decisions they make with 
patients with multimorbidity.
 ► Focus on decision-making processes and dysra-
tionality promoting factors.
 ► Potential to impact health practice and policy by 
identifying the main barriers and promoting factors 
to good decision-making in primary care with pa-
tients with multimorbidity.
 ► Limited to primary care physicians’ experiences in 
decision-making with patients with multimorbidi-
ty. Another review with patient perspectives would 
complement the phenomena and better inform the 
development of implementation strategies.
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decision and not surprisingly generalist specialties are the 
ones most prone to erroneous medical decision.9 10 First, 
for many years, medical research excluded patients with 
multimorbidity from clinical trials.11 This undermines 
and generates uncertainty and doubt in clinical decision 
with these patients.12 Second, quality is defined by clin-
ical practice guidelines written by authoritative specialty 
organisations which aim to improve medical care but 
tend to focus on a single organ or system and it is not 
clear how physicians estimate benefits and harms when 
applying them to patients with multimorbidity.13 Third, a 
complex web of positive (eg, accreditation, pay for perfor-
mance) or negative reinforcement (eg, administrative 
sanctions or loss of income) are built around disease-spe-
cific quality indicators. Fourth, productivity is measured 
by the number of clinical contacts or medical procedures 
per unit of time thereby decreasing consultation times.14 
All these factors create a primary care clinical encounter 
surrounded by high levels of uncertainty, complexity 
and a particularly demanding medical decision-making 
context.15 Qualitative research confirms that physicians 
feel less than confident in applying the guidelines and 
recommendations. They perceive that guidelines ignore 
contextual variables, seldom consider multimorbidity, 
sociopersonal context and patient preferences, and ulti-
mately are not considered useful because they add to the 
complexity of real-world decision-making.16 17
In summary, multimorbidity is ever more common and 
challenges physicians with increased uncertainty and 
complexity. Yet, healthcare systems have evolved towards 
a fragmented, single-disease care, failing to answer to 
this epidemiological transition.18 This is the paradoxical 
reality of primary care under which healthcare decisions 
are made.
The theoretical framework of medical decision-making
Cognitive psychology’s most consensual and known model 
for human decision-making is the dual process theory.19 
This model states that decision-making is the result of 
the integration between two cognitive systems. System 1, 
or the intuitive approach, is experiential and works based 
on fast and frugal heuristics and pattern recognition that 
triggers an automated mode of thinking.20 System 2, or 
the analytical approach, is characterised by being a delib-
erated, slower and rational thinking process. Under this 
system, people use deductive reasoning to test hypotheses 
and solve problems.20 21 This theory has been adapted 
for clinical decision-making and proposes that clinical 
reasoning and decision-making are the result of a perma-
nent interaction between the two systems.22
Croskerry defined optimal medical decision-making as 
the one that is logical, evidence based, follows the laws 
of science and probability and leads to decisions that are 
consistent with rational choice theory.22 Under this defi-
nition, rationality is an essential characteristic of good 
decision-making. Resulting from the analysis of different 
theories and models, a core set of five principles of rational 
decision has been proposed.23 These principles determine 
rational decision as the one that weights benefits and 
harms in order to achieve a goal; it is usually surrounded 
by uncertainty; it is informed by human cognitive architec-
ture (dual processing system); it depends on the context 
and epistemological, environmental and computational 
constraints of human brains and finally the decision is 
closely linked to ethics and moral values.23 Substantial 
gaps still limit our understanding of how these princi-
ples interact with cognitive bias leading to dysrationality 
in our decisions.22 24 Multimorbidity (with its implicit 
uncertainty and complexity) is an interesting condition 
to explore these gaps.25
The need for real-world research
Research in clinical reasoning and medical decision in 
a real-world context is needed, particularly with expe-
rienced physicians and how to embrace uncertainty in 
primary care.11 15 21 22 26–28 This research is particularly 
demanding in a chronic diseases context. Outcomes are 
not immediate and, in many circumstances, have to be 
defined case to case as in the complex or frail patient, 
making decision awareness and self-evaluation difficult 
tasks for the clinician.
In primary care, qualitative research on decision-making 
with patients with multimorbidity has explored physicians’ 
perspectives on patient management,29 organisational 
issues30 and prescribing decisions.9 To our knowledge, no 
review has compiled information regarding the way clini-
cians think and rational decision-making promoting factors. 
To improve good clinical judgement by ensuring it is more 
rational, but at the same time tailored to each patient’s 
unique characteristics, we need to better understand the 
way primary care physicians think, and which forces play 
a role and affect each of their medical decisions.
Objectives
The aim of the present review is to identify and synthe-
sise available qualitative evidence about primary care 
physician decision-making when attending patients with 
multimorbidity.
The main research question under study is the 
following:
According to available qualitative research, which 
facilitators and barriers are perceived by primary 
care physicians on decision-making with patients with 
multimorbidity?
MEthOds
Preferred Reporting Items for Systematic Reviews and 
Meta-Analyses Protocol (PRISMA-P) guidelines were 
followed to elaborate this protocol.31 See online supple-
mentary additional file 1 for PRISMA-P checklist applica-
tion on this protocol.
A thematic synthesis approach will be used to allow 
identification of key categories and themes from the 
qualitative data. This method aims to generate descriptive 
themes from line-by-line coding and the translation of 
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concepts from one study to another, as well as analytical 
themes, allowing new insights and interpretations beyond 
the content of the original studies.32 33
Eligibility criteria
Types of studies
The current review will consider qualitative research 
studies. This includes any study that uses qualitative 
methods for data collection such as interviews (indi-
vidual and focus group), observation as well as qualita-
tive methods for data analysis such as thematic analysis. 
Mixed-method studies will be considered if the applied 
qualitative methodology was as previously described.
Types of participants
The review will consider qualitative studies enrolling 
general practitioner/primary care physicians/family 
physicians.
Context and phenomena of interest
The context of the studies is primary care and the review 
will include studies that evaluate family physicians’ 
perspectives/opinions/perceptions on decision-making 
concerning the management of patients with multimor-
bidity. For this purpose, ‘multimorbidity’ will be consid-
ered as the co-occurrence of more than one chronic 
condition in an individual. We recognised that many 
studies until now did not made a clear distinction between 
multimorbidity and comorbidity and for that reason 
studies considering comorbidity may be included.34 Also, 
‘decision’ will be considered a situation where a course of 
action or recommendation was followed among one or 
several possible alternatives.
Information sources
The databases to be searched include PubMed, CINAHL, 
PsycINFO, Embase and Web of Science. The search for 
unpublished studies will include ProQuest dissertations 
and theses. We aim to find both published and unpub-
lished studies.
We will also search other resources such as the refer-
ence list of included studies, grey literature including 
government or non-governmental organisation reports. 
The original study authors will be contacted for clarifica-
tion if needed.
search strategy
We will include studies published in Portuguese, Spanish 
and English language (due to limited funding for transla-
tors) and there will be no date limit. Since decision-making 
has been studied for decades, this broad timeframe will 
ensure that all relevant studies on this topic are included 
in the systematic review.
The search strategy is presented in online supplemen-
tary additional file 2.
Patients and public
Patients and the public were not involved in this study.
study rECOrds
data management
Study screening and selection will be conducted using 
Mendeley software and Google spreadsheets.
selection process
Two authors (DSR and PFS) will independently screen 
titles and read the abstracts for papers with relevant 
titles. Full papers will be retrieved for papers with rele-
vant abstracts and reviewed by the two researchers. The 
full text of potentially eligible articles will be screened for 
inclusion in the review by DSR and NB. Disagreements 
will be resolved by discussion and consensus or with a 
third author (BH). The reasons for exclusion of studies 
in this last screening stage will be recorded, tabulated and 
published with the final paper. If the included studies are 
50 or more, a purposeful sampling method will be used to 
select the ones from which data will be extracted.35
data collection process
DSR and NB will consider and collect all of the text 
labelled as findings/results and discussion/conclusions/
interpretations in the original study reports selected for 
inclusion in the review.32 Data will be extracted verbatim 
from study papers directly into NVivo-11 software (QSR 
International).
data items
For each of the included study, the following additional 
information will be collected by DSR: authors; title; year(s) 
of data collection; year of publication; study population; 
phenomena of interest; study setting; study country; 
theoretical framework; data collection method used (eg, 
interviews, focus groups, document analysis, etc.). NB will 
assess original studies for confirmation. Disagreements 
will be resolved by discussion and consensus or with a 
third author (BH). The researchers will look for family 
physicians’ views/perspectives on situations where a 
course of action or recommendation was followed among 
one or several possible alternatives. These data will be 
recorded, tabulated and published with the final paper.
Outcomes and synthesis strategy
The data will be analysed according to established guide-
lines on thematic synthesis.32 This method consists of a 
three-step approach to the synthesis of qualitative data. 
First, the results from qualitative studies will be coded line 
by line according to content and meaning.
This process will require rereading and recoding, as well 
as discussion between the research team to determine the 
need for new codes or the re-evaluation of existing ones. 
The analysis will be theoretically driven by the literature 
on cognitive reasoning models such as the dual process 
theory22 through a deductive approach. Moreover, the 
researchers will remain aware of new concepts that may 
emerge from the data itself. Accordingly, the construc-
tion of descriptive themes will be based on the transla-
tion of concepts from one study to another, which means 
recognising the same concepts across studies, and in the 
 o
n
 13 M
ay 2019 by guest. Protected by copyright.
http://bmjopen.bmj.com/
BM
J O
pen: first published as 10.1136/bmjopen-2018-023832 on 3 April 2019. Downloaded from 
4 Silvério Rodrigues D, et al. BMJ Open 2019;9:e023832. doi:10.1136/bmjopen-2018-023832
Open access 
development of a hierarchical coding structure based on 
the similarities and differences between the codes.
The third stage of thematic synthesis, as described by 
Thomas and Harden,32 implies an iterative analysis of 
the results of stages 1 and 2 generating new themes that 
emerge transversally to all review studies. This last step 
of thematic synthesis goes beyond the content of the 
original studies, with new concepts and understandings 
emerging from the descriptive themes being organised 
into analytical themes.
This process will be carried by DSR and NB consulting 
with the research team. At this point, interpretations 
of information and barrier themes that primary care 
physicians value when making decisions with patients 
with multimorbidity will emerge. All these stages of data 
synthesis will be recorded in NVivo-11 to allow for an 
auditable track. The findings of the synthesis process will 
be presented by grouping textual excerpts from included 
studies that represent similar meanings or themes. When-
ever that grouping is not possible, a narrative form will 
be used.
risk of bias in individual studies
The methodological quality of the studies selected for 
retrieval will be assessed by two independent reviewers 
(DSR and NB) before inclusion in the review using the 
CASP tool.36 Any disagreements that arise between the 
reviewers will be resolved through discussion, or with a 
third reviewer (AA). Quality assessment will not be used 
to exclude studies.
Confidence in cumulative evidence
The Confidence in the Evidence from Reviews of Qualita-
tive research (CERQual) approach will be used to assess 
how much confidence to place in findings from the qual-
itative evidence synthesis.37 This assessment of confidence 
in the review findings is based on four components: the 
methodological limitations of the qualitative studies contrib-
uting to a review finding; the relevance to the review ques-
tion of the studies contributing to a review finding; the 
coherence of the review finding; and the adequacy of data 
supporting a review finding.37 Findings will be classified 
as having high, moderate, low or very low confidence. DSR 
and NB will independently apply the CERQual tool to the 
review findings. Disagreements will be resolved by discus-
sion and consensus. If disagreements persist, a third 
author (BH) will be consulted. CERQual Qualitative 
Evidence Profiles and Summary of Qualitative Findings 
table will be recorded and published with the final paper.
rEPOrtIng
This protocol was created using the PRISMA-P Statement 
for reporting systematic review protocols.31
The qualitative systematic review study report will follow 
the Enhancing Transparency in Reporting the synthesis 
of Qualitative research statement for reporting syntheses 
of qualitative studies.38
dIsCussIOn
Research in clinical reasoning and medical decision in 
a real-world context is needed, particularly with expe-
rienced physicians10 21 26–28 This review will increase 
knowledge and awareness by more accurately identifying 
physicians’ perceptions about the factors that play a role 
in their decision-making. It will focus on decision-making 
processes and rationality-promoting factors. This different 
‘lens’ will allow us to enhance existing systematic reviews 
of qualitative research about multimorbidity which so far 
have mostly focused on organisational issues.
We have reasons to believe that the main flaws in deci-
sion-making are probably inherent in the way physicians 
think, rather than in clinical knowledge deficits. For 
example, it could be predicted that, among other dysra-
tionality promoters, the tendency to avoid the complexity 
of multimorbidity may play a significant role. This system-
atic review will provide evidence that will support or 
contradict that idea.
Results from this systematic review will have the poten-
tial to impact health practice and policy by identifying 
the main promoters and barriers of decision-making 
in primary care with patients with multimorbidity. The 
results may allow the improvement of knowledge trans-
ference strategies or the creation of new ones. Ultimately, 
they will be useful for informing practice physicians, in 
creating tools that can help decision-making, in improving 
medical education, in further academic research and for 
private industry or public health policy decision-makers .
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